← 返回

TIL(肿瘤浸润淋巴细胞)的多样起源与性质:感染假说

英文原题:Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis.

查看英文原题

Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis.

PubMed 2026/07/16(内容时间) J Immunother Cancer Q1 · IF 11.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

19 世纪,Rudolf Virchow 在肿瘤中观察到淋巴细胞浸润,并提出癌症可能与炎症相关。当前对于TIL(肿瘤浸润淋巴细胞)来源的解释,主要建立在癌细胞与免疫系统相互作用的基础上。该模型提出时,人们尚未认识到肿瘤常被微生物成分感染或定植,也未考虑肿瘤内部可能存在细菌特异性和病毒特异性 T 细胞。虽然微生物暴露相关的多个方面仍在研究中,但其对肿瘤微环境和抗肿瘤免疫应答的影响可能很大,因为病原体可直接或间接促使TIL(肿瘤浸润淋巴细胞)募集。关于TIL(肿瘤浸润淋巴细胞)起源的“感染假说”补充了经典的肿瘤免疫编辑假说,为全面理解肿瘤生态系统提供了新途径,也提示癌症治疗应更细致地考虑肿瘤环境中淋巴细胞与病原体可能相互关联的作用。

展开英文摘要原文

In the 19th century, Rudolf Virchow observed lymphocyte infiltration in tumors and suggested a potential link between cancer and inflammation. Current explanations for the origin of tumor-infiltrating lymphocytes are based on the interaction between cancer cells and the immune system. This model was proposed before it was recognized that tumors are frequently infected or colonized by microbial elements, suggesting the presence of bacteria-specific and virus-specific T cells within tumors.

While several aspects of this microbial experience remain under investigation, their impact on the tumor microenvironment and antitumor immune response may be significant, as the pathogens may elicit the direct or indirect recruitment of tumor-infiltrating lymphocytes.

This "Infection Hypothesis" regarding the origin of tumor-infiltrating lymphocytes complements the classical tumor immunoediting hypothesis, offers new avenues for a comprehensive understanding of the tumor ecosystem, and highlights the need for more nuanced cancer treatment approaches that account for the potential interconnected roles of lymphocytes and pathogens in the tumor milieu.

论文信息

作者
Gomez-Manzano C、Shin DH、Alvarez-Breckenridge C、Gillard AG、Morad G、Puduvalli VK、Alonso MM、Lang FF
单位
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA jfueyo@mdanderson.org cmanzano@mdanderson.org.United States
文献类型
综述
期刊
Journal for immunotherapy of cancer2026 Jul 16
原文标识
PubMed 42463282 · DOI 10.1136/jitc-2026-015822